257.80USD-0.70%Mkt Cap: 17.03B $P/E: 20.03Today
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for …
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
Key Statistics
Company
Market Cap17.03B $
Enterprise Value16.39B $
Revenue (TTM)1.05B $
Gross Profit625.22M $
Net Income (TTM)-228.03M $
Revenue/Share16.89 USD
Last Price257.80 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)20.03
P/E (Forward)26.76
PEG—
EV/EBITDA62.20
EV/Revenue15.65
P/S15.96
P/B10.06
EPS (TTM)12.72
EPS (Forward)9.52
52W Range
160.8685% of range274.89
52W High274.89 USD
52W Low160.86 USD
Profitability
Gross Margin86.82%
Oper. Margin64.98%
EBITDA Margin25.16%
Profit Margin-31.67%
ROE140.05%
ROA-17.51%
Growth
Revenue Growth114.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF53.90M $
CapEx (TTM)8.48M $
FCF Margin1.22%
FCF Yield0.07%
Net Debt-362.19M $
Net Debt/EBITDA-1.37
Balance Sheet
Debt/Equity-5.35
Current Ratio2.99
Quick Ratio2.23
Book Value/Sh25.33 USD
Cash/Share12.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)314.09 USD
Upside (mean)+21.8%
Target Range264.30 USD – 365.22 USD
$264.30+21.8% to mean$365.22
# Analysts19
Ownership
Shares Out.65.59M
Float65.65M
Insiders0.78%
Institutions103.38%
Short Interest
Short Ratio6.5d
Short % Float6.15%
Short % Out.5.19%
Shares Short3.40M
Short (prev mo.)3.28M
Technical
SMA 50251.33 (+2.6%)
SMA 200229.44 (+12.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)828.60K
Avg Vol (10d)545.34K
Technical Indicators
RSI (14)59.1
MACD9.5175
MACD Signal7.0196
MACD Hist.+2.4979
BB Upper283.07 USD
BB Middle239.28 USD
BB Lower195.49 USD
BB Width36.60%
ATR (14)11.95 USD
Vol Ratio (20d)0.56x